| 000 -LEADER |
|---|
| fixed length control field |
01857cam a22002298a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200123100328.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
110420s2011 nyu b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781841848297 (hardback : alk. paper) |
| 041 07 - Language |
|---|
| Language code of text/sound track or separate title |
eng |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.994061 |
| Edition number |
23 |
| Item number |
C215 |
| 245 00 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Cancer vaccines : |
| Remainder of title |
from research to clinical practice / |
| Statement of responsibility, etc |
edited by Adrian Bot, Mihail Obrocea, Francesco Marincola. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
New York : |
| Name of publisher, distributor, etc |
Informa Healthcare, |
| Date of publication, distribution, etc |
2011. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
viii, 280 p. ; |
| Dimensions |
26 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
"Recent advances in immunology and biology have opened new horizons in cancer therapy, included in the expanding array of cancer treatment options, which are immunotherapies, or cancer vaccines, for both solid and blood borne cancers. Cancer Vaccines: Challenges and Opportunities in Translation is the first text in the field to bring immunotherapy treatments from the laboratory trial to the bedside for the practicing oncologist. Cancer Vaccines: Challenges and Opportunities in Translation: critically analyzes the most promising classes of investigational immunotherapies, integrating their scientific rationale and clinical potential, discusses "theranostics" as pertaining to immunotherapy, i.e., using molecular diagnostics to identify patients that would most likely benefit from a therapy, presents the new paradigm of biomarker guided R&D and clinical development in immunotherapy of cancer and reviews bottlenecks in translational process of immunotherapies and offers strategies to resolve them"--Provided by publisher. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer vaccines. |
| 9 (RLIN) |
35131 |
|
|---|
| Topical term or geographic name as entry element |
Cancer Vaccines |
| General subdivision |
therapeutic use. |
| 9 (RLIN) |
35132 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Bot, Adrian. |
| 9 (RLIN) |
35133 |
| Relator term |
editor |
|
|---|
| Personal name |
Obrocea, Mihail. |
| 9 (RLIN) |
35134 |
| Relator term |
editor |
|
|---|
| Personal name |
Marincola, Francesco M. |
| 9 (RLIN) |
35135 |
| Relator term |
editor |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
Book |
